Verywell Health: Perlmutter Cancer Center Medical Oncologist Discusses New Treatment for Early Breast Cancer
Photo: ihoe/Getty
The U.S. Food and Drug Administration (FDA) recently approved the cancer drug olaparib (Lynparza) for the treatment of people with high-risk early breast cancer. Olaparib, which was previously approved for the treatment of certain metastatic cancers, has been studied extensively in ovarian cancer, Nancy Chan, MD, director of breast cancer clinical research at 嘿嘿视频 Health鈥檚 Perlmutter Cancer Center, tells Verywell Health.
鈥淭his is a treatment approach to further reduce the risk of recurrence in this high-risk population,鈥 says Dr. Chan, a member of the faculty in the at NYU Grossman School of Medicine. 鈥淚t is overall well tolerated because it is not chemotherapy.鈥
Read more from .
听
听
